COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The first case of coronavirus disease 2019 (COVID-19) was reported in Wuhan, Hubei Province, China, in December 2019, marking a pivotal moment in human history [...].
References
1.
Clerbaux L, Mayasich S, Munoz A, Soares H, Petrillo M, Albertini M
. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. J Clin Med. 2022; 11(19).
PMC: 9573230.
DOI: 10.3390/jcm11195691.
View
2.
Ryu J, Kang S, Jung S, Lee S, Kang S
. Psychological Effects and Medication Adherence among Korean Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic: A Single-Center Survey. J Clin Med. 2022; 11(11).
PMC: 9181113.
DOI: 10.3390/jcm11113034.
View
3.
Clerbaux L, Fillipovska J, Munoz A, Petrillo M, Coecke S, Amorim M
. Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. J Clin Med. 2022; 11(18).
PMC: 9505288.
DOI: 10.3390/jcm11185400.
View
4.
Zabana Y, Marin-Jimenez I, Rodriguez-Lago I, Vera I, Martin-Arranz M, Guerra I
. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. J Clin Med. 2022; 11(2).
PMC: 8781643.
DOI: 10.3390/jcm11020421.
View
5.
Tokarczyk U, Kaliszewski K, Kopszak A, Nowak L, Sutkowska-Stepien K, Sroczynski M
. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value. J Clin Med. 2022; 11(15).
PMC: 9369475.
DOI: 10.3390/jcm11154490.
View